Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia | MicrobiomeTrials← Back to trialsNCT07680803
Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-07-06Est. Completion: 2028-10
Enrollment target: 9 participants Locations- Ospedale Pediatrico Bambino Gesù, Rome, Lazio, Italy
- Ospedale San Raffaele, Milan, Lombardy, Italy
Other microbiome trials you might be interested in
Thalassemia IntermediaThalassemia MajorGrowth DelayPuberty, Delayed
There are nearly 300,000 patients with severe or intermediate thalassemia in China. Growth retardation is the most signi…
Tianjin, ChinaEst. completion Oct 31, 2026
Beta Thalassemia Transfusion Dependent
Thalassemia is a group of recessively inherited hemoglobin disorders characterized by reduced or no production of hemogl…
Multiple LocationsEst. completion Dec 2028